James George Robinson, Director at NYMOX PHARMACEUTICAL CORP (NYMX), bought 7,000 shares at $1.72 ($12K) on 2019-07-10, disclosed to the SEC on 2019-07-12.
Open-market purchase of $12k NYMX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.72 | 100 | $172 | 1.4% |
| 2 | $1.72 | 600 | $1K | 8.5% |
| 3 | $1.73 | 166 | $287 | 2.4% |
| 4 | $1.73 | 300 | $519 | 4.3% |
| 5 | $1.73 | 5,834 | $10K | 83.4% |
| Total | $1.73 avg | 7,000 |
| $12K |
| 100% |
| Filing → |
| NYMX | BUY | 2022-05-06 | $3.8M | — | Filing → |
| NYMX | BUY | 2021-04-27 | $83K | — | Filing → |
| NYMX | BUY | 2019-07-10 | $11K | — | Filing → |